NVRO Add to watchlist $5.84 +0.00 (+0.00%) Last updated: Apr 16, 2026 00:44
52-Week Range
$5.84
$4.67 $5.84 $7.01

Fundamentals Overview

Nevro Corp. is in the middle of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/B 0.94 P/S 0.55

Risk (Beta)

0.82 — in line vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 39% confidence Risk: Moderate Volatility — Beta 0.82. Diversify and only invest what you can afford to lose.

Pressures (Sell):

Sentiment weakening (5 downgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$224.09M
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$4.67 - $7.01
Volume vs Avg
N/A
Beta
0.82

About

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells...
Sector: Healthcare
Headquarters: US
Employees: 1,099
IPO Date: Nov 2014
Website: www.nevro.com
Beta: 0.82 (Less volatile than market)

Ratings & Grades at a Glance

Recent institutional grades: majority downgrades. Current institutional positions: Equal Weight: 3, Hold: 7, Market Perform: 1, Neutral: 7, Peer Perform: 1, Sector Perform: 3, Sell: 2, Underweight: 6.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-95.04; current price is $5.84. That’s a -1727.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) N/A
PEG (TTM) N/A
P/B (TTM) 0.94
P/S (TTM) 0.55
Liquidity & enterprise
Current Ratio (TTM) 4.62
Quick Ratio (TTM) 3.62
Cash Ratio (TTM) 0.92
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -27.77%
Gross margin (TTM) 65.98%
Operating margin (TTM) -30.9%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for NVRO.

Analyst Sentiment at a Glance

Sentiment Weakening
Equal Weight 3Hold 7Market Perform 1Neutral 7Peer Perform 1Sector Perform 3Sell 2Underweight 6
3 upgrades, 5 downgrades
Price Target Consensus
Current $5.84
Median $7.00
Consensus $30.32
Low consensus $4.00
High consensus $125.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Canaccord Genuity maintain Hold Hold 2025-02-07
Piper Sandler upgrade Underweight Neutral 2025-02-07
Truist Securities maintain Hold Hold 2024-12-18
Citigroup maintain Neutral Neutral 2024-12-11
Wells Fargo maintain Equal Weight Equal Weight 2024-12-11
Canaccord Genuity maintain Hold Hold 2024-12-09
Morgan Stanley downgrade Equal Weight Underweight 2024-12-02
Canaccord Genuity maintain Hold Hold 2024-11-12
RBC Capital maintain Sector Perform Sector Perform 2024-11-12
Baird maintain Neutral Neutral 2024-11-12
Piper Sandler maintain Underweight Underweight 2024-11-12
Citigroup maintain Neutral Neutral 2024-10-01
Citigroup upgrade Sell Neutral 2024-08-09
Wolfe Research upgrade Underperform Peer Perform 2024-08-08
Truist Securities maintain Hold Hold 2024-08-08
Wells Fargo downgrade Equal Weight Underweight 2024-08-07
JMP Securities downgrade Market Outperform Market Perform 2024-08-07
Piper Sandler maintain Underweight Underweight 2024-08-07
Baird maintain Neutral Neutral 2024-08-07
RBC Capital maintain Sector Perform Sector Perform 2024-08-07
JP Morgan downgrade Neutral Underweight 2024-08-07
Truist Securities maintain Hold Hold 2024-07-16
Morgan Stanley maintain Equal Weight Equal Weight 2024-07-15
Citigroup maintain Sell Sell 2024-07-10
Citigroup downgrade Neutral Sell 2024-05-22
Canaccord Genuity maintain Hold Hold 2024-05-08
Piper Sandler maintain Underweight Underweight 2024-05-08
Wells Fargo maintain Equal Weight Equal Weight 2024-05-08
RBC Capital maintain Sector Perform Sector Perform 2024-04-15
Mizuho maintain Neutral Neutral 2024-04-11